Research Activity

• Design and synthesis of heterocyclic compounds as anticancer and anti-diabetic agents.
• Development of new strategies and concepts in synthetic organic chemistry towards sustainable synthesis of NCEs for anti-cancer drug discovery.
• Computer aided drug designing, docking, simulation studies and study of (quantitative) structure activity relationship.
• Transition metal catalyzed C-H activation reactions of unreactive C-H bond for the synthesis of anticancer and neuroprotective agents.
• Design and construction of fluorine containing scaffolds of pharmaceutical importance via C- H Bond activation.
• Process development of Active Pharmaceutical Ingredients (APIs).
• Re purposing of existing drug molecules for improved PK/PD profiling by modification of non pharmacophoric parts.
• Design and synthesis of peptide-nucleic acids (PNA) targeting m RNA and DNA related to oncology and neurological disorders.
• Synthesis of peptides and peptido-mimetics for targeted delivery and organocatalysis.